Background: Telogen Effluvium (TE) is the most common cause of diffuse hair loss in adult females. It may be a sequale of various metabolic alterations such as hormonal changes, malnutrition especially iron deficiency in premenopausal women. Objectives: This study aimed to estimate prevalence of TE, explore its associated factors and measure the effect of iron supplementation among women in childbearing period attending Damero family health center. Methods: A cross-sectional study was conducted in Damero Family health center. The study embraced 305 women in childbearing period aged (19-45) years attended the selected Family center for any medical services during the period of data collection. Participants were assessed clinically through comprehensive history (socioeconomic characteristics, menstrual, family and dietary history), physical examination (general, scalp and hair examination) and laboratory investigations included (complete blood count and serum ferritin levels). Telogen Effluvium improvement was assessed after 4 weeks of 600 mg daily oral iron supplementation. Results: This study shows that among 305 studied women in the childbearing period, 85 women (27.9%) had telogen effluvium. The most significant factor associated with Telogen Effluvium was iron deficiency anemia (p = 0.002, Odds ratio=3.9) followed by irregular menstruation (p 0.01, Odds ratio=1.6). In most of the participants Telogen Effluvium improved after 4 weeks of oral iron supplementation. Conclusion: There was a significant association between iron deficiency anemia and telogen effluvium. Moreover, there was an obvious improvement in TE after 4 weeks oral iron supplementation. Keywords: Telogen effluvium, iron deficiency anemia, females in the childbearing period, iron supplementation Introduction: Hair loss is a common health issue in the primary care setting and it affects men and women of all ages and can affect all hair-bearing areas of the body. (1) It is normal to shed between 50-100 hairs per day. (2) The hair cycle is divided into three phases: anagen (86%), catagen (1%), and telogen (13%). (3, 4) With telogen effluvium (TE), the ratio shifts to anagen (70%) and Telogen (30%), with daily shedding of up to 300 hairs. (5) Telogen effluvium is characterized by diffuse hair shedding, often with an acute onset. also exists with chronic form with a more insidious onset and a longer duration. (6) Although the exact prevalence rate of telogen effluvium is unknown, hair loss affects over 25% of women in the developed countries and one study in Makkah, Saudi Arabia found it to be 1.74% among women. (7) The TE has many causes include :
Iron is involved in many processes within the hair follicle, suggesting that iron deficiency (ID) could disrupt hair synthesis. (12) It is described that irondependent genes in the hair follicle bulge region may be affected by ID. [13] Hemoglobin concentration can be used to screen for iron deficiency, whereas serum ferritin concentration can be used to confirm iron deficiency. (14) 
